VRPX - Virpax Pharmaceuticals Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2021-08-17    (Delayed quote data   2025-01-06)
Last
 0.39		 Change
 ⇓ -0.03   (0.00%)		 Volume
  523,964
Open
 0.41		 High
 0.42		 Low
 0.39
8EMA (Daily)
 0.39		 40EMA (Daily)
 0.45		 50EMA (Daily)
 0.48		 STO (Daily)
 47.619		 MACD Hist (Daily)
 0.031
8EMA (Weekly)
 0.439		 40EMA (Weekly)
 1.40		 50EMA (Weekly)
 1.92		 STO (Weekly)
 13.158		 MACD Hist (Weekly)
 0.147
Company Profile
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com